Realistically, what harm can the experiments described in the article do to the general population?
It's so hard to do anything, even design diagnostic tests, that requires FDA approval that personally I'd avoid any startup that had that on their route to revenue.
It's kind of a shame, and countries where it's easier to develop new treatments and tests are likely to take the lead.
It's so hard to do anything, even design diagnostic tests, that requires FDA approval that personally I'd avoid any startup that had that on their route to revenue.
It's kind of a shame, and countries where it's easier to develop new treatments and tests are likely to take the lead.